Study of BMS-986168 in Patients With Progressive Supranuclear Palsy

Condition:   Progressive Supranuclear Palsy Interventions:   Biological: BMS-986168;   Biological: Placebo Sponsor:   Bristol-Myers Squibb Not yet recruiting - verified February 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials